EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ETV4 Promotes Colorectal Cancer Progression by Reprogramming Asparagine Metabolism to Remodel the Stromal Microenvironment

Dujiang Fu iD, Meijia Zhang, Maoping Cai, Miao Wang, Ziao Huang, Zesheng Lin, Yixin Liu, Wang Qian, Guopeng Chen, Yuxing Liang, Dongyi Wei, Jing Xie und 3 weitere

Advanced Science · 2026-05 · 13 (26)

DOI: 10.1002/advs.202516557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.03.2026. Verfasst von Dujiang Fu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Medical Oncology, Hubei Cancer Clinical Study Center & Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospi…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Colorectal Neoplasms, Asparagine, Adenovirus E1A Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province, Innovation Platform Support Project of Zhongnan Hospital, Wuhan University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) lethality is largely driven by liver metastasis and the associated tumor microenvironment (TME). This study identifies ETS variant transcription factor 4 (ETV4) as a central integrator of oncogenic signaling, metabolism, and stromal remodeling. In CRC cells, hepatocyte growth factor (HGF)/MET signaling induces ETV4 via an ERK1/2–p65 pathway. ETV4, in turn, directly activates MET and asparagine synthetase (ASNS), creating a positive feedback loop that amplifies MET signaling and elevates intracellular asparagine (Asn). Tumor‐derived Asn acts as a paracrine signal that induces inflammatory cancer‐associated fibroblast (iCAF) like activation in hepatic stellate cells (HSCs) and promotes iCAF polarization in primary CAFs, leading to enhanced HGF secretion that further stimulates MET + tumor cells. Genetic and pharmacologic disruption of this axis attenuates CRC growth and metastatic traits in vitro and in mouse models. Notably, combined inhibition of HGF/MET signaling and Asn metabolism produces greater antitumor activity than either monotherapy. Together, these data delineate an HGF/MET → ETV4 → MET/ASNS → asparagine → iCAFs and iCAF‐like HSCs → HGF circuit that links signal amplification, metabolic reprogramming, and niche conditioning, and provide a rationale for therapeutic strategies co‑targeting HGF/MET and Asn pathways in advanced CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentColorectal NeoplasmsAsparagineAdenovirus E1A ProteinsProto-Oncogene Proteins c-etsAnimalsHumansMiceHepatocyte Growth FactorSignal TransductionCell Line, TumorMetabolic ReprogrammingProto-Oncogene Proteins c-metDisease Progression

Stichwörter der Autor:innen

ETV4HGF/MET signalingasparagine metabolismcolorectal cancerstromal microenvironment

Substanzen

ETV4 protein, humanAsparagineAdenovirus E1A ProteinsHepatocyte Growth FactorProto-Oncogene Proteins c-etsProto-Oncogene Proteins c-met

Autor:innen und Institutionen

  • Department of Radiation and Medical Oncology, Hubei Cancer Clinical Study Center & Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Radiotherapy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
  • Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: Dujiang Fu, Yongchang Wei

Förderung

  • Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province
  • Innovation Platform Support Project of Zhongnan Hospital, Wuhan University
  • National Natural Science Foundation of China

Zitieren

APA

Fu, D., Zhang, M., Cai, M., Wang, M., Huang, Z., Lin, Z., Liu, Y., Qian, W., Chen, G., Liang, Y., Wei, D., Xie, J., Yan, P., Qu, Y., & Wei, Y. (2026). ETV4 Promotes Colorectal Cancer Progression by Reprogramming Asparagine Metabolism to Remodel the Stromal Microenvironment. Advanced Science, 13(26). https://doi.org/10.1002/advs.202516557

Vancouver

Fu D, Zhang M, Cai M, Wang M, Huang Z, Lin Z, et al. ETV4 Promotes Colorectal Cancer Progression by Reprogramming Asparagine Metabolism to Remodel the Stromal Microenvironment. Advanced Science. 2026;13(26). doi:10.1002/advs.202516557

BibTeX
@article{Fu2026,
  author = {Fu, Dujiang and Zhang, Meijia and Cai, Maoping and Wang, Miao and Huang, Ziao and Lin, Zesheng and Liu, Yixin and Qian, Wang and Chen, Guopeng and Liang, Yuxing and Wei, Dongyi and Xie, Jing and Yan, Picheng and Qu, Yuanyuan and Wei, Yongchang},
  title = {ETV4 Promotes Colorectal Cancer Progression by Reprogramming Asparagine Metabolism to Remodel the Stromal Microenvironment},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {26},
  doi = {10.1002/advs.202516557}
}
Kostenlos starten →